| Pre | 90 min | 24 h | 48 h | 72 h |
---|---|---|---|---|---|
Placebo | |||||
CRP, mg/dL | |||||
 Control | 0.07 ± 0.04 | 0.07 ± 0.04 | 0.07 ± 0.03 | 0.06 ± 0.02 | 0.05 ± 0.02 |
 Exercise | 0.08 ± 0.02 | 0.11 ± 0.05 | 0.15 ± 0.05* | 0.11 ± 0.05 | 0.10 ± 0.03 |
CK, U/L | |||||
 Control | 94 ± 10 | 98 ± 8 | 89 ± 8 | 87 ± 9 | 90 ± 11 |
 Exercise | 93 ± 8 | 126 ± 13 | 396 ± 72*, ** | 257 ± 48*, ** | 192 ± 32* |
Herb | |||||
CRP, mg/dL | |||||
 Control | 0.13 ± 0.05 | 0.14 ± 0.05 | 0.11 ± 0.04 | 0.11 ± 0.04 | 0.11 ± 0.03 |
 Exercise | 0.10 ± 0.03 | 0.09 ± 0.03 | 0.15 ± 0.03* | 0.10 ± 0.02 | 0.10 ± 0.02 |
CK, U/L | |||||
 Control | 110 ± 12 | 108 ± 9 | 119 ± 17 | 109 ± 11 | 113 ± 16 |
 Exercise | 106 ± 9 | 195 ± 51* | 291 ± 35*, ** | 204 ± 26*, ** | 151 ± 20 |
TBARs, μM | |||||
 Placebo | 7.1 ± 1.1 | 8.1 ± 1.5 | 7.9 ± 1.0 | 6.5 ± 1.0 | - |
 Herb | 7.0 ± 1.0 | 6.6 ± 0.8 | 8.1 ± 0.9 | 5.7 ± 0.6 | - |
IL-6, pg/ml | |||||
 Placebo | 0.44 ± 0.1 | 0.69 ± 0.1* | 0.32 ± 0.1 | 0.46 ± 0.1 | - |
 Herb | 0.50 ± 0.2 | 0.45 ± 0.1 | 0.23 ± 0.1* | 0.29 ± 0.1 | - |
TNF-α, pg/ml | |||||
 Placebo | 0.45 ± 0.14 | 0.28 ± 0.06 | 0.30 ± 0.06 | 0.30 ± 0.06 | - |
 Herb | 0.44 ± 0.06 | 0.34 ± 0.06 | 0.38 ± 0.08 | 0.34 ± 0.06 | - |